CULIACAN, Mexico - The cartel operatives came to the homeless encampment carrying syringes filled with their latest fentanyl formula. The offer was simple, according to two men living at the camp in north-west Mexico: up to US$30 (S$40.80) for anyone willing to inject themselves with the concoction.
One of the men, Mr Pedro Lopez Camacho, said he volunteered repeatedly - at times, the operatives were visiting every day. They watched the drug take effect, Mr Lopez Camacho said, snapping photos and filming his reaction. He survived, but he said he saw many others who did not.
"When it's really strong, it knocks you out or kills you," said Mr Lopez Camacho of the drugs he and others were given. "The people here died."
This is how far Mexican cartels will go to dominate the fentanyl business.
Global efforts to crack down on the synthetic opioid have made it harder for these criminal groups to find the chemical compounds they need to produce the drug. The original source, China, has restricted exports of the necessary raw ingredients, pushing the cartels to come up with new and extremely risky ways to maintain fentanyl production and potency.
The experimentation, members of the cartels say, involves combining the drug with a wider range of additives - including animal sedatives and other dangerous anaesthetics.
To test their results, the criminals who make the fentanyl for the cartels, often called cooks, say they inject their experimental mixtures into human subjects as well as rabbits and chickens.
If the rabbits survive beyond 90 seconds, the drug is deemed too weak to be sold to Americans, according to six cooks and two US Embassy officials who monitor cartel activity. The US officials said that when Mexican law enforcement units have raided fentanyl labs, they have at times found the premises riddled with dead animals used for testing.
This story is from the December 29, 2024 edition of The Straits Times.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the December 29, 2024 edition of The Straits Times.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Thunder Strike For The 13Th Time
They post another strong third quarter to extend winning streak with Clippers win
Capital Delight To Make A Point
1 Country Dancer ticks plenty of boxes, backing up quickly and stepping up in trip. He impressed two starts ago with a breakthrough win before producing a fast-finishing second down the 1,000m Sha Tin straight.
Victory Eases Ong Into New KL Set-Up
Moving team wholesale key to champion trainer, even Queiroz will reunite at CNY
Filipino dads and grandmothers are making waves on TikTok
From performing quirky dance moves to donning funny costumes, some tap the social media platform to help put food on the table.
South-east Asia to make adjustments
In this contested world, how will South-east Asia fare?
Risks for Russia and eye on Israel's moves
One other geopolitical uncertainty haunts South-east Asia in 2025: How the two hot wars will pan out.
A Test for Japan, a Reversal of Fortunes on Korean Peninsula
In a region where the gravest threat is viewed as coming from China – and the other East Asian giant, South Korea – is temporarily in turmoil, Japan's Prime Minister Shigeru Ishiba asserts that the lynchpin for East Asia's security is the US-Japan alliance.
Reckoning in US-China ties looms as Trump prepares to take office
Watching all this across the Pacific will be the same adversary Donald Trump faced in 2017, husbanding an economy that is weaker by all accounts. Can President Xi Jinping, shaken by a property meltdown and ebbing foreign investment, call his bluff?
Why 2025 could be a make-or-break year for the US in Asia
The superpower has been ceding ground to China in Asia and Trump's hard-nosed agenda may make matters worse.
Crypto industry dreams of a golden era under Trump
The sector expects lighter regulation and wider adoption under the President-elect, but some worry about systemic risks.